Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Differentiated thyroid cancer: millions spent with no tangible gain?

Furuya-Kanamori L, Sedrakyan A, Onitilo AA, Bagheri N, Glasziou P, Doi SAR.

Endocr Relat Cancer. 2018 Jan;25(1):51-57. doi: 10.1530/ERC-17-0397. Epub 2017 Oct 17.

PMID:
29042396
2.

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP, Mulcahy MF, Armstrong KI, Nabbout NH, Kalnicki S, El-Rayes BF, Onitilo AA, Moriarty DJ, Fitzgerald TJ, Benson AB 3rd.

J Clin Oncol. 2017 Mar;35(7):718-726. doi: 10.1200/JCO.2016.69.1667. Epub 2017 Jan 9.

3.

Discriminatory power of common genetic variants in personalized breast cancer diagnosis.

Wu Y, Abbey CK, Liu J, Ong I, Peissig P, Onitilo AA, Fan J, Yuan M, Burnside ES.

Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9787. pii: 978706. Epub 2016 Mar 24.

4.

The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study.

Doi SA, Furuya-Kanamori L, Engel JM, Jamal MH, Stankowski RV, Barkun J, Onitilo AA.

Cancer Causes Control. 2016 Jul;27(7):941-6. doi: 10.1007/s10552-016-0761-2. Epub 2016 May 26.

PMID:
27228990
5.

Sexual health assessment and counseling: oncology nurses' perceptions, practices, and perceived barriers.

Depke JL, Onitilo AA.

J Community Support Oncol. 2015 Dec;13(12):442-3. doi: 10.12788/jcso.0174.

PMID:
26863875
6.

Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation.

Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES.

J Med Imaging (Bellingham). 2015 Oct;2(4):041005. doi: 10.1117/1.JMI.2.4.041005. Epub 2015 Aug 17.

7.

Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy.

Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD, Peissig PL, Trentham-Dietz A, Kitchner T, Fan J, Yuan M.

Acad Radiol. 2016 Jan;23(1):62-9. doi: 10.1016/j.acra.2015.09.007. Epub 2015 Oct 26.

8.

Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.

Shanle EK, Onitilo AA, Huang W, Kim K, Zang C, Engel JM, Xu W, Wisinski KB.

Am J Transl Res. 2015 Jul 15;7(7):1246-59. eCollection 2015.

9.

Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis.

Liu J, Wu Y, Ong I, Page D, Peissig P, McCarty C, Onitilo AA, Burnside E.

AMIA Jt Summits Transl Sci Proc. 2015 Mar 25;2015:107-11. eCollection 2015.

10.

Validation of the CoRE Questionnaire for a Medical Journal Peer Review.

Doi SA, Salzman-Scott SA, Onitilo AA.

Account Res. 2016;23(1):47-52. doi: 10.1080/08989621.2014.1002835.

PMID:
26192007
11.

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.

Fenske TS, Shah NM, Kim KM, Saha S, Zhang C, Baim AE, Farnen JP, Onitilo AA, Blank JH, Ahuja H, Wassenaar T, Qamar R, Mansky P, Traynor AM, Mattison RJ, Kahl BS.

Cancer. 2015 Oct 1;121(19):3465-71. doi: 10.1002/cncr.29502. Epub 2015 Jun 16.

12.

Navigating the Needs of Rural Women with Breast Cancer: A Breast Care Program.

Depke JL, Boreen A, Onitilo AA.

Clin Med Res. 2015 Dec;13(3-4):149-55. doi: 10.3121/cmr.2015.1260. Epub 2015 Jun 8.

13.

Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.

Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ.

J Community Support Oncol. 2015 May;13(5):195-201. doi: 10.12788/jcso.0135. No abstract available.

14.

All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis.

Engel JM, Stankowski-Drengler TJ, Stankowski RV, Liang H, Doi SA, Onitilo AA.

AJR Am J Roentgenol. 2015 Apr;204(4):898-902. doi: 10.2214/AJR.14.12666.

PMID:
25794084
15.

New genetic variants improve personalized breast cancer diagnosis.

Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Trentham-Dietz A, Burnside E.

AMIA Jt Summits Transl Sci Proc. 2014 Apr 7;2014:83-9. eCollection 2014.

16.

Developing a clinical utility framework to evaluate prediction models in radiogenomics.

Wu Y, Liu J, Del Rio AM, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES.

Proc SPIE Int Soc Opt Eng. 2015 Feb 21;9416. pii: 941617. Epub 2015 Mar 17.

17.

Overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma.

Yellu MR, Engel JM, Ghose A, Onitilo AA.

Hematol Oncol. 2016 Mar;34(1):2-8. doi: 10.1002/hon.2185. Epub 2014 Dec 19. Review. Retraction in: Hematol Oncol. 2017 Mar;35(1):142.

PMID:
25524637
18.

Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.

Onitilo AA, Engel JM, Stankowski RV, Doi SA.

Clin Med Res. 2015 Jun;13(2):65-73. doi: 10.3121/cmr.2014.1245. Epub 2014 Dec 8.

19.

McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.

Jamal MH, Doi SA, Moser AJ, Dumitra S, abou Khalil J, Simoneau E, Chaudhury P, Onitilo AA, Metrakos P, Barkun JS.

World J Gastroenterol. 2014 Sep 14;20(34):12226-32. doi: 10.3748/wjg.v20.i34.12226.

20.

Gangliocytic paraganglioma, a rare ampullary tumour treated with open transduodenal resection and sphincteroplasty.

Rafiullah, Tanimu S, Onitilo AA.

BMJ Case Rep. 2014 Jul 2;2014. pii: bcr2013202941. doi: 10.1136/bcr-2013-202941.

21.

Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.

Onitilo AA, Engel JM, Stankowski RV.

Ther Adv Drug Saf. 2014 Aug;5(4):154-66. doi: 10.1177/2042098614529603. Review.

22.

Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis.

Onitilo AA, Liang H, Stankowski RV, Engel JM, Broton M, Doi SA, Miskowiak DA.

Rural Remote Health. 2014;14(3):2738. Epub 2014 Jul 14.

23.

Antithrombin levels are unaffected by warfarin use.

Sanfelippo MJ, Engel JM, Onitilo AA.

Arch Pathol Lab Med. 2014 Jul;138(7):967-8. doi: 10.5858/arpa.2013-0065-OA.

PMID:
24979180
24.

A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record.

Onitilo AA, Stankowski RV, Berg RL, Engel JM, Williams GM, Doi SA.

BMC Med Inform Decis Mak. 2014 May 9;14:38. doi: 10.1186/1472-6947-14-38.

25.

Oesophageal papillomatosis, not amenable to endoscopic therapies, treated with oesophagectomy.

Tanimu S, Rafiullah, Resnick J, Onitilo AA.

BMJ Case Rep. 2014 Apr 30;2014. pii: bcr2013200195. doi: 10.1136/bcr-2013-200195.

26.

Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.

Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA; CERGEN Study Team.

PLoS One. 2014 May 1;9(5):e94977. doi: 10.1371/journal.pone.0094977. eCollection 2014.

27.

Is it time for the Cochrane Collaboration to reconsider its meta-analysis methodology?

Onitilo AA.

Clin Med Res. 2014 Sep;12(1-2):2-3. doi: 10.3121/cmr.2013.1188-1209. Epub 2014 Feb 26. No abstract available.

28.

Genetic variants improve breast cancer risk prediction on mammograms.

Liu J, Page D, Nassif H, Shavlik J, Peissig P, McCarty C, Onitilo AA, Burnside E.

AMIA Annu Symp Proc. 2013 Nov 16;2013:876-85. eCollection 2013.

29.

Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer.

Onitilo AA, Onesti JK, Single RM, Engel JM, James TA, Aiello Bowles EJ, Spencer Feigelson H, Barney T, McCahill LE.

PLoS One. 2013 Dec 20;8(12):e84535. doi: 10.1371/journal.pone.0084535. eCollection 2013.

30.

Comparing the value of mammographic features and genetic variants in breast cancer risk prediction.

Wu Y, Liu J, Page D, Peissig P, McCarty C, Onitilo AA, Burnside ES.

AMIA Annu Symp Proc. 2014 Nov 14;2014:1228-37. eCollection 2014.

31.

A core-item reviewer evaluation (CoRE) system for manuscript peer review.

Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA.

Account Res. 2014;21(2):109-21. doi: 10.1080/08989621.2014.847664.

PMID:
24228975
32.

Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Mankarios D, Baade P, Youl P, Mortimer RH, Onitilo AA, Russell A, Doi SA.

Endocrine. 2014 Jun;46(2):300-8. doi: 10.1007/s12020-013-0078-9. Epub 2013 Oct 31.

PMID:
24174176
33.

Reply: To PMID 23490543.

Onitilo AA, Engel JM, James TA, Aiello Bowles EJ, McCahill LE, Feigelson HS.

J Am Coll Surg. 2013 Nov;217(5):960-2. doi: 10.1016/j.jamcollsurg.2013.07.396. No abstract available.

PMID:
24139222
34.

Peripancreatic cystic lymphangioma diagnosed by endoscopic ultrasound/fine-needle aspiration: a rare mesenchymal tumour.

Tanimu S, Rafiullah, Resnick J, Onitilo AA.

BMJ Case Rep. 2013 Oct 3;2013. pii: bcr2013200210. doi: 10.1136/bcr-2013-200210.

35.

Type 2 diabetes mellitus, glycemic control, and cancer risk.

Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA.

Eur J Cancer Prev. 2014 Mar;23(2):134-40. doi: 10.1097/CEJ.0b013e3283656394.

PMID:
23962874
36.

Mammography utilization: patient characteristics and breast cancer stage at diagnosis.

Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak DA, Broton M, Doi SA.

AJR Am J Roentgenol. 2013 Nov;201(5):1057-63. doi: 10.2214/AJR.13.10733. Epub 2013 Aug 16.

PMID:
23952790
37.

Increased risk of colon cancer in men in the pre-diabetes phase.

Onitilo AA, Berg RL, Engel JM, Glurich I, Stankowski RV, Williams G, Doi SA.

PLoS One. 2013 Aug 2;8(8):e70426. doi: 10.1371/journal.pone.0070426. Print 2013.

38.

Reliability of reviewer ratings in the manuscript peer review process: an opportunity for improvement.

Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA.

Account Res. 2013;20(4):270-84. doi: 10.1080/08989621.2013.804345.

PMID:
23805832
39.

Breast and prostate cancer survivors in a diabetic cohort: results from the Living with Diabetes Study.

Onitilo AA, Donald M, Stankowski RV, Engel JM, Williams G, Doi SA.

Clin Med Res. 2013 Dec;11(4):210-8. doi: 10.3121/cmr.2013.1156. Epub 2013 May 13.

40.

Prostate cancer risk in pre-diabetic men: a matched cohort study.

Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA.

Clin Med Res. 2013 Dec;11(4):201-9. doi: 10.3121/cmr.2013.1160. Epub 2013 May 8.

41.

Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.

Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA; CERGEN study team.

Genet Med. 2013 Dec;15(12):933-40. doi: 10.1038/gim.2013.43. Epub 2013 May 2.

42.

Adequate lymph node recovery improves survival in colorectal cancer patients.

Onitilo AA, Stankowski RV, Engel JM, Doi SA.

J Surg Oncol. 2013 Jun;107(8):828-34. doi: 10.1002/jso.23332. Epub 2013 Apr 16.

43.

Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase.

Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA.

Eur J Cancer Prev. 2014 Mar;23(2):76-83. doi: 10.1097/CEJ.0b013e32836162aa.

PMID:
23571511
44.
45.

Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen.

Onitilo AA, Doi SA, Engel JM, Glurich I, Berg R.

Thromb Res. 2013 Jun;131(6):567-8. doi: 10.1016/j.thromres.2013.01.035. Epub 2013 Feb 24. No abstract available.

PMID:
23497923
46.

Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study.

Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, Bakerman JE, McCahill LE.

J Am Coll Surg. 2013 May;216(5):966-75. doi: 10.1016/j.jamcollsurg.2013.01.011. Epub 2013 Mar 13.

47.

Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.

Glurich I, Chyou PH, Engel JM, Cross DS, Onitilo AA.

Clin Med Res. 2013 Feb;11(1):16-25. doi: 10.3121/cmr.2012.1101.

48.

A new NF1 variant in a patient with atypical manifestations.

Onitilo AA, Engel JM.

Am J Med Genet A. 2013 Feb;161A(2):389-92. doi: 10.1002/ajmg.a.35728. Epub 2013 Jan 15. No abstract available.

PMID:
23322702
49.

Anti-phospholipid antibodies in patients undergoing total joint replacement surgery.

Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking W, Yale SH, Mazza JJ.

Thrombosis. 2012;2012:142615. doi: 10.1155/2012/142615. Epub 2012 Oct 31.

50.

Utilization of HER2 genetic testing in a multi-institutional observational study.

Goddard KA, Bowles EJ, Feigelson HS, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA.

Am J Manag Care. 2012 Nov;18(11):704-12.

Supplemental Content

Loading ...
Support Center